View:
December 21, 2018
Wouter W. Latour
Chief Executive Officer
Vaxart, Inc.
290 Utah Ave
Suite 200
South San Francisco, CA 94080
Re: Vaxart, Inc.
Registration Statement on Form S-3
Filed December 20, 2018
File No. 333-228910
Dear Mr. Latour:
This is to advise you that we have not reviewed and will not review your
registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.
Please contact Donald Field at 202-551-3680 with any questions.
Sincerely,
Division of
Corporation Finance
Office of
Healthcare & Insurance